Search
for
Sort by
Research 481–510 of 890
- Beeinflussen Medikamente gegen das benigne Prostatasyndrom Stimmung oder Kognition?
- Psychoactive Agents in Dermatology
- Selective Sensing of Darolutamide and Thalidomide in Pharmaceutical Preparations and in Spiked Biofluids
- Microneedling as an adjunctive treatment for trichotillomania
- Spotlight Commentary: Importance of dose redefining in the process of drug repurposing
- Prediction of the Development of Depression in Patients with Autoimmune Thyroiditis and Hypothyroidism
- Hair Growth Promotion by δ-Opioid Receptor Activation
- Approach to the patient with hair loss
- Quality of Calcium Food Supplements: Evaluation Compared to Manufacturers’ Declarations
- WARFARIN-INDUCED ALOPECIA: A RARE CASE REPORT
- Finasteride prescribed for hair loss consistently leads to depression. Comment on ‘Depression risk of 5-alpha reductase inhibitors: impact of active-comparator versus non-drug user control groups on risk measurement’
- Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- 26-SNP Panel Aids Guiding Androgenetic Alopecia Therapy and Provides Insight into Mechanisms of Action
- A New Framework for Understanding Hair‐Driven Medical Decisions
- An Overview on Ethanopharmacological Profile of Bacopa Monniera
- Insights into the peripheral nature of persistent sexual dysfunction associated with post-finasteride, post-SSRI and post-accutane syndromes: lessons learned from a case study
- Placental Extracts, Proteins, and Hydrolyzed Proteins as Active Ingredients in Cosmetic Preparations for Hair Loss: A Systematic Review of Available Clinical Evidence
- The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database
- An overview of animal models induced by glucocorticoids
- Does treatment with clomipramine reduce cat psychogenic alopecia?
- COVID-19-induced Scalp Alopecia Treated Effectively with Stem Cell Serum
- Telogen Effluvium and Anesthesia Considerations: A Case Report
- A randomized comparative study between intralesional vitamin D3 and intralesional triamcinolone acetonide in the treatment of alopecia areata
- PSSD,PFS,PRSD: A perspective for aetiology and treatment
- An analytical study of serum ferritin, vitamin D, and thyroid function in females with diffuse hair loss
- PCOS and Hyperprolactinemia: Conflicting Conditions or Comorbidities?
- Chronic telogen effluvium in women: role of micronutrients, a case–control study in north of Iran
- Association of Alopecia Areata With Attention-Deficit/Hyperactivity Disorder Stimulant Medication: A Case-Control Study
- Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis